Lexi-Comp, Inc. Company Profile

14:48 EST 17th February 2019 | BioPortfolio

Lexi-Comp, Inc. was founded in 1978 and is located in the Western Reserve village of Hudson, Ohio. The company was originally established to create custom reference books for clinical laboratories. Since then, we have evolved into an industry-leading provider of comprehensive clinical information and advanced technology that provides healthcare professionals with the resources they need to improve point-of-care decisions. Our unbiased and clinically-relevant content is collected, validated, and published exclusively by Lexi-Comp, Inc. utilizing an editorial model that balances the demands of real-time publishing with a stringent peer-review process. Active surveillance of the FDA, pharmaceutical industry, and clinical literature is performed by our in-house team of clinicians, who research the latest findings on drugs, indications, warnings, and interactions. Through the years, we have also built relationships with over 100 outside authors and consultant editors who practice in the healthcare arena. They complete an external review process, providing multiple layers of analysis and expertise. All of these individuals have a relentless focus on content enhancement, which ensures continuously updated knowledge in our library of databases that is worthy of trust.
In addition to our in-house clinical team, the Lexi-Comp production staff constructs and maintains our databases. These diligent professionals work closely with our clients to provide valuable training and support. Our staff also includes information technology specialists, technical support representatives, and market experts who understand the daily challenges facing healthcare providers.


1100 Terex Road
United States of America


Phone: 330-650-6506
Fax: 330-656-4307

News Articles [15 Associated News Articles listed on BioPortfolio]

Health Wonk Review is up at Workers’ Comp Insider

It’s time for the Waning days of summer edition of the Health Wonk Review, hosted by Julie Ferguson at Workers’ Comp Insider. Go check it out. Although I have not had time for a lot of blo...

EMA's COMP issues positive opinion on orphan drug status for Santhera's POL6014 to treat cystic fibrosis

Santhera Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on orphan drug designation for POL60...

Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia

The designation to SLN124 was granted by the Committee for Orphan Medicinal Products (COMP), a committee of the European Medicines Agency (EMA). COMP after reviewing an application filed The post Sil...

News and press releases: Committee for Orphan Medicinal Products (COMP) elects new chair

Violeta Stoyanova-Beninska to begin three-year mandate at October meeting

MÄRKTE USA/Börse vor Fed-Entscheid im Plus - Hohe Kosten belasten Nike

NEW YORK (Dow Jones)--Bis zum Mittag (Ortszeit New York) bauen die US-Börsen ihre Gewinne noch etwas aus. Der Dow-Jones-Index gewinnt 0,2 Prozent auf 26.543 Punkte. Der S&P-500 und der Nasdaq-Comp...

Dyadic International, Inc.: Dyadic Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the "SEC") has declared the Comp...

Workers' Comp Often a Gateway to Opioid Abuse: Study

MONDAY, Oct. 29, 2018 -- Many injured workers turn to opioid painkillers for relief, and nearly 30 percent may still be taking them three months after their injury -- increasing the odds of addiction,...

The Waning Days of Summer Health Wonk Review

Julie Ferguson has posted the “The Waning Days of Summer” edition of this month’s Health Wonk Review at Workers’ Comp Insider.  Check it out!

Drugs and Medications [0 Results]


PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Cartilage oligomeric matrix protein is a novel notch ligand driving embryonic stem cell differentiation towards the smooth muscle lineage.

Cartilage oligomeric matrix protein (COMP), a protective component of vascular extracellular matrix (ECM), maintains the homeostasis of mature vascular smooth muscle cells (VSMCs). However, whether CO...

Serum COMP expression in individuals who sustained a youth sport-related intra-articular knee injury 3-10 years previously and uninjured matched controls.

This study investigates the relationship between a youth sport-related intra-articular knee injury and cartilage oligomeric matrix protein (COMP), a biomarker of cartilage turnover.

Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.

Obstructive sleep apnea (OSA) is highly prevalent and constitutes a major health hazard. Current pharmacotherapy is ineffective in correcting sleep-disordered breathing and is used adjunctively to add...

Long non-coding RNA transcriptome of uncharacterized samples can be accurately imputed using protein-coding genes.

Long non-coding RNAs (lncRNAs) play an important role in gene regulation and are increasingly being recognized as crucial mediators of disease pathogenesis. However, the vast majority of published tra...

Protective effect of a novel sigma-1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice.

Sigma-1 receptor (Sig-1R) is expressed at endoplasmic reticulum (ER) membranes, where it regulates a variety of specific physiological functions. However, the profile and exact roles of ER stress-rela...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

To evaluate the safety and efficacy of R-COMP in elderly patients with advanced aggressive NHL. Myocet (non-pegylated liposomal doxorubicin) replaces conventional doxorubicin in the R-CHO...

Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study

The research question is if there is a dose-response relationship between blood biomarkers for articular cartilage and the magnitude of physiological load. To investigate this load induced...

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma is the most prevalent subgroup within malignant lymphoma. Clinical benefit has been shown for the treatment with cyclophosphamide, doxorubicin, vincristin and...

Brain Mechanisms in Young Adults

The goal of this study is to use [C-11]NPA and amphetamine (oral, 0.5 mg/kg) to measure striatal dopamine transmission in prenatal cocaine exposed subjects (PCE) and comparison subjects (C...

Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

All patients enrolled in the study will have to be treated with a chemo immunotherapy scheme R-CHOP with doxorubicin, with doxorubicin analogue or non pegylated liposomal anthracycline (R-...

Companies [4 Associated Companies listed on BioPortfolio]

Lexi-Comp, Inc.

Lexi-Comp, Inc. was founded in 1978 and is located in the Western Reserve village of Hudson, Ohio. The company was originally established to create custom reference books for clinical laboratories. Si...

Xybion Corporation

Since its founding in 1977, Xybion has become the leading provider of software, services and consulting to global pharmaceutical, healthcare and other companies operating in highl...

Buxco Electronics

Temperature and Humidity MeasurementsThis configuration lets you monitor temperature and humidity within the animal chamber on its own or in addition to other unrestrained measurements. Useful in pre ...

Health Endeavors

Health Endeavors is a web-based software solution that provides 24/7 access to software solutions for hospitals and physicians. Subscriber service provides integrated solutions fo...

More Information about "Lexi-Comp, Inc." on BioPortfolio

We have published hundreds of Lexi-Comp, Inc. news stories on BioPortfolio along with dozens of Lexi-Comp, Inc. Clinical Trials and PubMed Articles about Lexi-Comp, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lexi-Comp, Inc. Companies in our database. You can also find out about relevant Lexi-Comp, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record